DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma

High‐throughput microarray technologies were used to study DNA methylation accompanied by transcriptional changes in follicular lymphoma (FL). Using Methylated CpG Island Amplification with Microarrays to study CpG Island DNA methylation in FL, we discovered widespread hypermethylation of homeobox genes and previously identified targets of polycomb repressive complex 2 (PRC2) in cell lines and primary tumors, but not in benign follicular hyperplasia (BFH). DNA methylation for HOXA11, HOXD10, HOXB7, HOXC12, PAX6, LHX9, SFMBT2, EN2, and PAX7 was independently validated in the RL cell line and HOXA11, HOXD10, PAX6, and EN2 in primary tumors. Combined Bisulfite Restriction Analysis (COBRA) also established DNA methylation for the previously identified PRC2 targets DCC, DES, GAD2, AQP5, GPR61, GRIA4, GJD2, and AMPH in FL but not in BFH. Gene expression analyses revealed 411 genes that were hypermethylated and transcriptionally repressed in RL, 74% of which were reactivated by the demethylating agent 5‐aza‐2′‐deoxycytidine (5‐azaD) plus or minus the histone deacetylase inhibitor trichostatin A (TSA). Forty genes were also downregulated in primary FL. Our results suggest that extensive hypermethylation in promoters of polycomb target genes is a characteristic of FL and that loss of expression of certain SUZ12 target genes could be functionally relevant for lymphomagenesis. © 2009 Wiley‐Liss, Inc.

[1]  M. Esteller.  Epigenetic changes in cancer , 2011, F1000 biology reports.

[2]  T. Cantz,et al.  Induced pluripotent stem cells generated without viral integration , 2009, Hepatology.

[3]  A. Riggs,et al.  A human B cell methylome at 100-base pair resolution. , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[5]  Gangning Liang,et al.  Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line , 2008, Proceedings of the National Academy of Sciences.

[6]  C. Shapiro,et al.  Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. , 2008, Carcinogenesis.

[7]  P. Evans,et al.  Roles of Kruppel-like factor 4 in normal homeostasis, cancer and stem cells , 2008 .

[8]  J. Xu,et al.  Downregulation of Krüppel‐like factor 9 in human colorectal cancer , 2008, Pathology international.

[9]  Michael G. Kharas,et al.  KLF4 is a FOXO target gene that suppresses B cell proliferation. , 2008, International immunology.

[10]  J. Licht,et al.  Epigenetic regulation of normal and malignant hematopoiesis , 2007, Oncogene.

[11]  Pearlly S Yan,et al.  High-throughput methylation profiling by MCA coupled to CpG island microarray. , 2007, Genome research.

[12]  Peter A. Jones,et al.  Epigenetic changes in cancer , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  Yi Guo,et al.  Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters , 2007, PLoS genetics.

[14]  S. Tangye,et al.  Decreased expression of Krüppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses , 2007, Proceedings of the National Academy of Sciences.

[15]  Qiang Yu,et al.  Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. , 2007, Genes & development.

[16]  Ian M. Carr,et al.  Sequence analysis and editing for bisulphite genomic sequencing projects , 2007, Nucleic acids research.

[17]  A. Riggs,et al.  Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay , 2007, Proceedings of the National Academy of Sciences.

[18]  Michael G. Kharas,et al.  KLF4 suppresses transformation of pre-B cells by ABL oncogenes. , 2007, Blood.

[19]  M. Fraga,et al.  Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN‐1) , 2006, The Journal of pathology.

[20]  J. Utikal,et al.  The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation , 2006, International journal of cancer.

[21]  S. Goerdt,et al.  Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. , 2006, The Journal of pathology.

[22]  Henriette O'Geen,et al.  Suz12 binds to silenced regions of the genome in a cell-type-specific manner. , 2006, Genome research.

[23]  C. Plass,et al.  DNA motifs associated with aberrant CpG island methylation. , 2006, Genomics.

[24]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[25]  G. Prendergast,et al.  RhoB facilitates c-Myc turnover by supporting efficient nuclear accumulation of GSK-3 , 2006, Oncogene.

[26]  S. Goerdt,et al.  Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis , 2006 .

[27]  P. Taghavi,et al.  Association of BMI1 with Polycomb Bodies Is Dynamic and Requires PRC2/EZH2 and the Maintenance DNA Methyltransferase DNMT1 , 2005, Molecular and Cellular Biology.

[28]  L. Staudt,et al.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.

[29]  G. Strathdee,et al.  Control of gene expression by CpG island methylation in normal cells. , 2004, Biochemical Society transactions.

[30]  Yi Zhang,et al.  SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. , 2004, Molecular cell.

[31]  V. Pirrotta,et al.  Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites , 2002, Cell.

[32]  Brigitte Wild,et al.  Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex , 2002, Cell.

[33]  Hengbin Wang,et al.  Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing , 2002, Science.

[34]  S. Friedman,et al.  KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer , 2001, Science.

[35]  Z. Y. Chen,et al.  Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. , 2000, Nucleic acids research.

[36]  C. Pucillo,et al.  Differential attachment of human neoplastic B cells to purified extracellular matrix molecules. , 1994, Blood.

[37]  D. Longo,et al.  Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines. , 1990, Journal of the National Cancer Institute.

[38]  L. Kearney,et al.  Establishment and characterization of three new malignant lymphoid cell lines , 1987, International journal of cancer.

[39]  M. T. McCabe,et al.  A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. , 2009, Cancer research.

[40]  T. Rauch,et al.  The MIRA method for DNA methylation analysis. , 2009, Methods in molecular biology.

[41]  R. Bende,et al.  Molecular pathways in follicular lymphoma , 2007, Leukemia.

[42]  Xin-Hua Feng,et al.  Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B). , 2002, Molecular cell.